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Not the average view of adipogenesis
A
merican men are 176.3 cm tall 
and weigh 86.6 kg. This state-
ment isn’t actually true, of 
course—it’s just an average that masks a 
huge diversity in body shape and size. Loo 
et al. reveal that only looking at the popula-
tion average of differentiating adipocytes 
hides a similar heterogeneity, and limits 
our ability to understand adipogenesis (1).
Adipocytes are the body’s fat-storing 
cells. As they develop from precursors, 
they express specific proteins such as 
adiponectin, and form large lipid droplets 
in their cytosol (2). Judged by methods—
such as Western blotting—that measure 
the average values of a cell population, 
these markers all increase in conjunction 
with one another. Lit-Hsin Loo, Steve 
Altschuler, Lani Wu, and their colleagues 
at UT Southwestern Medical Center, 
Dallas, Texas, were trying to model the 
signaling pathways that control fat metab-
olism in 3T3-L1 adipocytes when they 
realized that the cells were too heteroge-
neous to treat as a uniform population. 
Immunofluorescence revealed widely 
divergent levels of adiponectin and lipid 
droplets in each cell as they progressed 
through differentiation.
“We realized that we had to go to 
a different resolution,” says Altschuler. 
But while considering the cells as a sin-
gle homogenous group was too simple, 
analyzing each cell individually would 
make things too compli-
cated. Therefore, based on 
the adiponectin and lipid 
droplet levels measured by 
automated microscopy, Loo 
et al. clustered the cells into 
four different subpopula-
tions using an unbiased 
computer algorithm. “We 
looked at a very large number of cells,” 
explains Loo. “So we could see patterns 
that wouldn’t have been obvious if we’d 
only analyzed a small number.”
Surprisingly, none of the four sub-
populations consisted of cells with high 
amounts of both adiponectin and lipid 
droplets, even though the two markers 
increase simultaneously when measured 
in the population as a whole. Instead, the 
researchers identifi  ed one subpopulation 
(labeled S3) with higher adiponectin and 
lower lipid droplet levels, and another 
(S4) with low adiponectin but more lipid 
droplets. Several other markers thought to 
be linked were also shown to have distinct 
expression patterns in S3 and S4 cells. 
“It’s a lesson to us that there can be this 
illusion of correlation,” Altschuler admits.
The four subpopulations probably 
represent particular stages of adipogenesis, 
consistent with the idea that differentiating 
cells transit through distinct phenotypic 
states (3, 4). The proportion of adipocytes 
in each subpopulation changed over time, 
and time-lapse microscopy 
suggested that the cells shift 
from one state to another. S3 
cells seem to develop into 
S4 cells but, Wu explains, 
“people haven’t seen this 
before because the cells dif-
ferentiate asynchronously.” 
Thus, at the population level, 
adiponectin and lipid droplets increase 
together, even though they peak at different 
points during adipogenesis.
If the subpopulations correspond 
to distinct stages of differentiation, the 
researchers reasoned that they would re-
act to drug treatments in different ways. 
“Adipocytes respond to a variety of 
compounds, hormones, and fatty acids,” 
says Loo and, indeed, many of these 
factors had specifi  c effects on the sub-
populations in ways that are obscured by 
population-averaged measurements. The 
next question is to determine how these 
results on cultured adipocytes relate to 
the situation in vivo. One step will be to 
better defi  ne the different cellular states, 
perhaps by identifying unique biomarkers 
for each subpopulation.
Meanwhile, the group is interested in 
many other systems—including cancer—
in which heterogeneity among cells is a 
notable feature. “Our ultimate goal is to 
build better models of signal transduc-
tion,” says Altschuler. “To do this, we 
have to understand whether our data are 
coming from a heterogeneous system or 
not. When can you justify using a mean? 
We’re fi  nding that in many cases, you 
actually can’t. You have to decompose 
your population into more homogenous 
groups, and only then can you build 
your model.”
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Lani Wu, Lit-Hsin Loo, Steve Altschuler, and colleagues identiﬁ  ed four phenotypically distinct 
subpopulations within a heterogeneous mix of differentiating adipocytes (middle). Clustering 
individual cells together according to their levels of particular markers (right) offered a markedly 
different view of adipogenesis than seen with measurements averaged across the whole 
population—markers thought to be closely connected are actually inversely correlated at the 
single cell level.
“It’s a lesson 
to us that 
there can be 
this illusion of 
correlation.”
Study on cell heterogeneity offers a surprising twist to adipocyte differentiation.
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